USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Moravek Biochemicals, Inc.
Address:
577 Mercury Ln
Brea, CA 92621
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
Yes
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $140,924.00 3
SBIR Phase II $787,749.00 2

Award List:

CHEMICAL SYNTHESIS OF RADIOLABELED ANTITUMOR AGENTS

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$42,924.00
Agency:
HHS
Principal Investigator:
Josef Moravek , Principal Investigator
Abstract:
N/a

CHEMICAL SYNTHESIS OF RADIOLABELED ANTITUMOR AGENTS

Award Year / Program / Phase:
1987 / SBIR / Phase II
Award Amount:
$248,000.00
Agency:
HHS
Principal Investigator:
Josef Moravek , Principal Investigator
Abstract:
Knowledge of biologic mechanism of action of the different drugs and about the biochemical events in the progress of cancer disease is very valuable for the design of new drugs and therapies. tracer methodology using isotopically labeled drugs continues to be a powerful tool in obtaining such… More

"CHEMICAL SYNTHESIS OF C14, H3 AND S35 LABELED ANTI-AIDS AND ANTI-CANCER AGENTS

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$48,000.00
Agency:
HHS
Principal Investigator:
Moravek, Josef , Principal Investigator
Abstract:
The goal of this project is to maintain and operate a specialized laboratory for the synthesis of selected anti-cancer and anti-aids compounds labeled with carbon-14, tritium or sulfur-35. in addition, we will develop the radiosynthesis of such drugs selected by nci. the label will be incorporated… More

Synthesis of Labeled Antiaids and Anticancer Agents

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

Synthesis of Labeled Antiaids and Anticancer Agents

Award Year / Program / Phase:
1995 / SBIR / Phase II
Award Amount:
$539,749.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a